Tumor growth, immune cell populations in TME, and survival were analyzed.<h4>Results</h4>β-glucan elevated MHCII+DCs, meanwhile combination therapy increased the CD8+/Treg ratio, suggesting enhanced anti-tumor immunity. This evidence concerns the gene CD8A and neoplasm.